Suitable for Flow Cyt, IHC-Fr, IHC-P, IM, ICC/IF, ELISA. Cited in 37 publications.
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application Flow Cyt | Reactivity Expected | Dilution info - | Notes - |
Application IHC-Fr | Reactivity Expected | Dilution info - | Notes - |
Application IHC-P | Reactivity Expected | Dilution info - | Notes - |
Application IM | Reactivity Expected | Dilution info - | Notes - |
Application ICC/IF | Reactivity Reacts | Dilution info 1/1000 - 1/5000 | Notes - |
Application ELISA | Reactivity Expected | Dilution info 1/10000 - 1/50000 | Notes - |
Ig gamma-1 chain C region
Suitable for Flow Cyt, IHC-Fr, IHC-P, IM, ICC/IF, ELISA. Cited in 37 publications.
Preservative: 0.01% Sodium azide
Constituents: 1% BSA, 0.88% Sodium chloride, 0.424% Potassium phosphate solution
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Rat IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ab6840 was used at dilution 1/500 with the primary antibody Anti-BrdU antibody [BU1/75 (ICR1)] - Proliferation Marker ab6326 in ICC/IF. See the review on ab6326.
This data was developed using Anti-Cytokeratin 7 antibody [EP1620Y] ab68460, the same antibody clone in a different buffer formulation.
Lanes 1 - 4: Merged signal (red and green). Green - Anti-Cytokeratin 7 antibody [EP1620Y] ab68460 observed at 50 kDa. Red - loading control, Anti-GAPDH antibody [6C5] - Loading Control ab8245, observed at 37 kDa.
Anti-Cytokeratin 7 antibody [EP1620Y] ab68460 was shown to specifically react with KRT7 (Cytokeratin 7) in wild-type A549 cells as signal was lost in KRT7 knockout cells. Wild-type and KRT7 knockout samples were subjected to SDS-PAGE. Anti-Cytokeratin 7 antibody [EP1620Y] ab68460 and Anti-GAPDH antibody [6C5] - Loading Control ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/10000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
Lane 1: Wild-type A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2: KRT7 knockout A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 3: HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 4: MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rat IgG H&L (FITC) (ab6840) at 1/10000 dilution
Performed under reducing conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com